本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Gossamer Bio Inc.

1.24
-0.0300-2.36%
成交量:112.65万
成交额:140.44万
市值:2.82亿
市盈率:-5.48
高:1.29
开:1.27
低:1.20
收:1.27
数据加载中...
2024/03/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/05

重要事件披露

Form 8-K - Current report
2024/03/05

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/11

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/11

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/30

重要事件披露

Form 8-K - Current report
2023/11/27

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/10/20

重要事件披露

Form 8-K - Current report
2023/09/08

重要事件披露

Form 8-K - Current report
2023/08/25

SEC问询函

Form CORRESP - Correspondence
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/29

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/07/20

重要事件披露

Form 8-K - Current report